ANEST IWATA (6381) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Net sales rose 4.5% year-on-year to ¥27,060 million, driven by strong overseas sales in Europe, Americas, and China, while Japan remained weak.
Operating profit increased 3.3% year-on-year to ¥2,962 million, supported by improved cost-to-sales ratio despite higher labor costs.
Ordinary profit and net profit declined 12.4% and 16.3% year-on-year, mainly due to foreign exchange losses and margin pressures.
Interim dividend of ¥22 per share was paid as planned; annual dividend forecast is ¥50.00 per share.
Global economic recovery was gradual, with overseas strength offsetting domestic weakness.
Financial highlights
Net sales: ¥27,060 million (+4.5% YoY); operating profit: ¥2,962 million (+3.3% YoY); ordinary profit: ¥3,462 million (–12.4% YoY); net profit: ¥2,194 million (–16.3% YoY).
Gross profit margin improved to 45.9% (+1.0 pts YoY); SG&A expenses ratio increased to 35.0% (+1.2 pts YoY) due to higher labor costs.
Basic EPS decreased to ¥55.35 from ¥64.82 year-over-year.
Cash and cash equivalents at period end were ¥13,732 million, down 6.0% from March 31, 2024.
Operating cash flow increased 58.8% year-over-year to ¥3,040 million; investing and financing cash flows were negative.
Outlook and guidance
Full-year forecast unchanged: net sales ¥58,000 million (+8.6% YoY), operating profit ¥6,800 million (+10.1%), ordinary profit ¥7,800 million (+2.3%), net income ¥4,950 million (+0.4%), and EPS ¥123.91.
Annual dividend forecast is ¥50.00 per share.
Uncertainties remain regarding China’s economic slowdown, global monetary policies, currency trends, and geopolitical risks.
Overseas sales, especially in air energy and coating, are expected to drive growth; labor and investment costs to be offset by increased gross profit.
Latest events from ANEST IWATA
- Profits and sales fell, but financial stability and full-year guidance were maintained.6381
Q3 202610 Feb 2026 - Sales and profit fell, but FX gains and cash flow stability kept guidance unchanged.6381
Q2 202628 Nov 2025 - Q1 sales and profits declined, comprehensive income turned negative, but guidance is unchanged.6381
Q1 20268 Aug 2025 - Sales rose but profits fell on higher costs; full-year outlook maintained amid global risks.6381
Q1 202513 Jun 2025 - Sales up, profits down; FY2025 targets higher sales, lower earnings, and a dividend increase.6381
Q4 20256 Jun 2025 - Profit outlook cut as China lags and costs rise, but investment and R&D remain on track.6381
Q3 20255 Jun 2025